Popular search terms:
Search Results
79 results found-
January is National Mentoring Month, but some seek STEM-focused learning year-round.
https://www.cslbehring.ca/news/2018/20180130-mentoring-month -
Dr. Andrea Douglas of CSL Behring discusses bringing women into STEM fields and raising them to the executive ranks.
https://www.cslbehring.ca/news/2018/20180124-women-in-stem -
Welcome to CSL Behring Canada. Our portfolio of innovative medicines includes a wide range of recombinant and plasma-derived products for treating bleeding disorders, immune deficiencies, and chronic inflammatory demyelinating polyneuropathy, as well as hereditary angioedema and Alpha-1 Antitrypsin Deficiency.
https://www.cslbehring.ca/news/2019/38th-annual-john-molson -
Bienvenue chez CSL Behring Canada. Notre panoplie de médicaments innovants comprend une large gamme de produits recombinants et dérivés du plasma pour le traitement des troubles de la coagulation, des déficits immunitaires et de la polyneuropathie démyélinisante inflammatoire chronique, ainsi que l'angio-œdème héréditaire et le déficit en alpha-1 antitrypsine.
https://www.cslbehring.ca/fr-fr/nouvelles/2023/csl-again-named-among-americas-best-employers-by-forbes -
The Global Leadership Group at CSL believes in creating an environment that fosters innovation and strives to meet the needs of patients.
https://www.cslbehring.ca/our-company/global-leadership-group -
Here you can find an overview of all the products that we offer in Canada.
https://www.cslbehring.ca/products/product-list -
Welcome to CSL Behring Canada. Our portfolio of innovative medicines includes a wide range of recombinant and plasma-derived products for treating bleeding disorders, immune deficiencies, and chronic inflammatory demyelinating polyneuropathy, as well as hereditary angioedema and Alpha-1 Antitrypsin Deficiency.
https://www.cslbehring.ca/accessibility-statement -
Welcome to CSL Behring Canada. Our portfolio of innovative medicines includes a wide range of recombinant and plasma-derived products for treating bleeding disorders, immune deficiencies, and chronic inflammatory demyelinating polyneuropathy, as well as hereditary angioedema and Alpha-1 Antitrypsin Deficiency.
https://www.cslbehring.ca/terms-of-use -
CSL Behring is committed to advancing scientific knowledge, fostering excellence, and supporting future medical researchers. We also support advocacy work of rare disease patient groups.
https://www.cslbehring.ca/research-and-development/awards-and-grants/publication-grants